Express Scripts Holding Company Q1 Outlook Underwhelms After Mixed Q4 Results
February 15, 2017 at 04:53 AM EST
The St. Louis-based pharmacy benefits manager reported adjusted Q4 EPS $1.88, which was $0.01 better than Wall Street consensus estimate of $1.87. Revenues fell 5% from last year to $24.86 billion, missing analysts’ expectation of $26.29 billion.
